Advertisement

Topics

Novartis Gets FDA Nod For Leukemia Gene Cell Therapy

11:47 EDT 30 Aug 2017 | FinanzNachrichten

BASEL (dpa-AFX) - In a significant breakthrough, Novartis AG's CAR-T cell therapy for young people with acute lymphoblastic leukemia was approved by the Food and Drug Administration on Wednesday. ...

Original Article: Novartis Gets FDA Nod For Leukemia Gene Cell Therapy

NEXT ARTICLE

More From BioPortfolio on "Novartis Gets FDA Nod For Leukemia Gene Cell Therapy"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...